Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jun 1;25(2):201-207.
doi: 10.22540/JMNI-25-201.

Efficacy of Atorvastatin Against Venous Thromboembolism After Total Hip Arthroplasty

Affiliations
Randomized Controlled Trial

Efficacy of Atorvastatin Against Venous Thromboembolism After Total Hip Arthroplasty

Huajiang Liu et al. J Musculoskelet Neuronal Interact. .

Abstract

Objective: We examined the effect of atorvastatin on the prevention and management of venous thromboembolism (VTE) after total hip arthroplasty (THA).

Methods: A total of 300 patients were equally assigned to a treatment group and a control group. The treatment group received oral atorvastatin calcium tablets (20 mg/day) starting on the first day after surgery. The incidence of deep vein thrombosis, pulmonary embolism, incision hemorrhage, postoperative infection, and incision ecchymosis were evaluated in both groups. Additionally, hemoglobin levels, hematocrit, visual analog scale (VAS) pain scores, Harris hip scores, and Harris grading were compared between the two groups.

Results: The incidence of deep vein thrombosis, pulmonary embolism, incision hemorrhage, postoperative infection, and incision ecchymosis was significantly lower in the treatment group after atorvastatin intervention (P < 0.05 vs. control group). The hemoglobin levels, hematocrits, and VAS scores in the treatment group were significantly lower on days 1, 3, 7, and 14 after surgery (P < 0.05 vs. control group). The Harris hip scores and the number of patients with excellent Harris grading were significantly higher in the treatment group (P < 0.05 vs. control group).

Conclusion: Atorvastatin is effective in preventing VTE after THA and in improving postoperative joint function.

Keywords: Atorvastatin; Total Hip Arthroplasty; Venous Thromboembolism.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest.

Similar articles

References

    1. Lieberman JR, Bell JA. Venous Thromboembolic Prophylaxis After Total Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2021;103:1556–64. - PubMed
    1. Ren Z, Yuan Y, Qi W, Li Y, Wang P. The incidence and risk factors of deep venous thrombosis in lower extremities following surgically treated femoral shaft fracture:a retrospective case-control study. J Orthop Surg Res. 2021;16(1):446. - PMC - PubMed
    1. Group CS, Sidhu VS, Kelly TL, et al. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty:The CRISTAL Randomized Trial. JAMA. 2022;328:719–27. - PMC - PubMed
    1. Zhang Y, Qian Q, Qian G, Sun G. Laboratory monitoring of rivaroxaban and assessment of its bleeding risk. Br J Biomed Sci. 2016;73:134–9. - PubMed
    1. Sorensen HT, Horvath-Puho E, Sogaard KK, et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism:a population-based case-control study. J Thromb Haemost. 2009;7:521–8. - PubMed

Publication types

MeSH terms

Substances